Welcome to our dedicated page for Sono Tek SEC filings (Ticker: SOTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ultrasonic coating may sound simple, yet Sono-Tek’s SEC filings can stretch past 250 pages of dense engineering jargon and revenue breakouts. Finding where the company discloses semiconductor backlog or which executive just sold shares is time-consuming.
Stock Titan solves that pain. Our AI reads every Sono-Tek annual report 10-K simplified, every Sono-Tek quarterly earnings report 10-Q filing, and each Sono-Tek 8-K material events explained, then delivers plain-English summaries, key metrics, and red-flag alerts. Want immediate visibility into Sono-Tek insider trading Form 4 transactions? We stream Sono-Tek Form 4 insider transactions real-time so you can monitor executive stock moves before the market reacts.
Use our platform to:
- Compare R&D spending on new hydrogen-fuel coatings across successive 10-Qs.
- Track Sono-Tek proxy statement executive compensation to evaluate management incentives.
- Spot segment revenue shifts in medical device coatings without wading through footnotes.
- Receive AI-driven alerts when a fresh contract is disclosed in an 8-K.
From “understanding Sono-Tek SEC documents with AI” to detailed Sono-Tek earnings report filing analysis, Stock Titan keeps every filing type in one place—updated the moment EDGAR releases it and decoded so you can act with confidence.
Sono-Tek Corporation (SOTK) insider filing: CEO Stephen R. Harshbarger reported an option grant on 08/21/2025. The report shows acquisition of 29,268 Sono-Tek options with an exercise price of $3.25 per share.
The options become exercisable on 08/21/2026 and expire on 08/21/2035. Following the reported transaction, Mr. Harshbarger beneficially owns 83,184 shares (direct).
Stephen J. Bagley, CFO of Sono-Tek Corporation (SOTK), reported multiple open-market sales of common stock on August 18-19, 2025. The filings show four dispositions at prices between $3.34 and $3.36 per share, reducing his direct holdings stepwise to 34,254 shares. The Form 4 is signed and filed to disclose these changes in beneficial ownership.
Stephen J. Bagley, CFO of Sono-Tek Corporation, reported a sale of 350 shares of common stock on 08/07/2025 at $3.33 per share. After the transaction he directly beneficially owns 36,147 shares. The Form 4 shows only this routine officer sale and lists no derivative transactions or other material changes to his ownership.
Sono-Tek Corp. (SOTK) mailed its DEF 14A for the 21 Aug 2025 AGM (record date 21 Jul 2025, Milton NY, 10 a.m.). Shareholders will:
- Elect four directors (Coccio, Riemer, Harshbarger, Warshaw) to 2027.
- Ratify CBIZ CPAs as independent auditor, replacing Marcum after its business sale.
- Cast advisory votes on NEO compensation and on pay-vote frequency (board backs three-year cycle).
Board consists of eight members—six are NASDAQ-defined independent. Dr Christopher Coccio became Executive Chair in Jan 2024; R. Stephen Harshbarger is CEO. FY 2025 NEO pay: CEO $385.5k (incl. $60k option grant at $4.12), CFO $254.6k, COO $334.8k. Non-employee directors earn $2,500 per meeting plus 5,333 options.
Equity plans: 2013 Plan (211k options outstanding, closed) and 2023 Plan (220k outstanding, 2.5 m share limit). Change-of-control severance equals two years’ comp (CEO estimate $659k). Outstanding shares total 15.73 m; Emancipation Management and related entities own 34.8%. Audit fees FY 2025 were $185k; no tax or other fees. Board recommends voting FOR all proposals.
FAQ
What is the current stock price of Sono Tek (SOTK)?
What is the market cap of Sono Tek (SOTK)?
